Drug intelligence / Profile preview

bitter hops extract

Development stage
Preclinical
Lead developer
Calocurb
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Bitter hops extract is an investigational botanical extract derived from a New Zealand commercial variety of hop flowers (*Humulus lupulus* L.) using a food-grade supercritical carbon dioxide extraction process. It is marketed as a gut-targeted dietary supplement under the brand name Amarasate (and formulated in the commercial product Calocurb) for appetite suppression and weight management. The extract contains concentrated bitter hop acids, including alpha-acids (such as humulone) and beta-acids (such as lupulone), which act as ligands for human bitter taste receptors (TAS2Rs) located on enteroendocrine cells in the gastrointestinal tract. Activation of these receptors triggers the 'bitter brake' satiety mechanism, stimulating the release of appetite-regulating gut hormones, including cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide YY (PYY), which signal fullness to the brain and reduce energy intake.

Brand names
AmarasateCalocurb
Other names
Humulus lupulus extractbitter hops extractsupercritical CO2 extract of hop flowers
02

Targets

TAS2R (Taste receptor type 2 family)

Beyond the preview

Go deeper on bitter hops extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bitter hops extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call